Testing effectiveness (Phase 2)WithdrawnNCT06328036
What this trial is testing
Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
National Cancer Institute (NCI)